"Atrium Health Levine Cancer Institute provides access to top-ranked physician expertise, groundbreaking clinical trials and the latest cancer treatments across the Carolinas."

During the past decade, Cleveland Hematology and Oncology Associates PC conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 4 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 3 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Cleveland Hematology and Oncology Associates PC" #1 collaborator was "National Cancer Institute (NCI)" with 4 trials as a collaborator, "NRG Oncology" with 2 trials as a collaborator and "Cancer Prevention Pharmaceuticals, Inc." with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Cleveland Hematology and Oncology Associates PC" are "Breast Cancer" (2 trials), "Breast Ductal Carcinoma In Situ" (2 trials), "Recurrent Breast Carcinoma" (2 trials), "Stage IB Lung Non-Small Cell Carcinoma AJCC v7" (2 trials) and "Stage II Lung Non-Small Cell Cancer AJCC v7" (2 trials). Many other conditions were trialed in "Cleveland Hematology and Oncology Associates PC" in a lesser frequency.

Most popular intervention types in "Cleveland Hematology and Oncology Associates PC" are "Drug" (9 trials), "Other" (9 trials), "Biological" (3 trials), "Procedure" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (6 trials), "Clinical Observation" (3 trials), "Crizotinib" (2 trials), "Paclitaxel" (2 trials) and "Placebo Administration" (2 trials). Other intervention names were less common.

The vast majority of trials in "Cleveland Hematology and Oncology Associates PC" are 5 trials for "All" genders and 5 trials for "Female" genders.

Currently, there are NaN active trials in "Cleveland Hematology and Oncology Associates PC". undefined are not yet recruiting, 3 are recruiting, 6 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Cleveland Hematology and Oncology Associates PC, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Cleveland Hematology and Oncology Associates PC, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".